HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aila M Rissanen Selected Research

Triglycerides (Triacylglycerol)

7/2008Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.
4/2005Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aila M Rissanen Research Topics

Disease

2Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2008 - 04/2005
2Hypertension (High Blood Pressure)
07/2008 - 04/2005
2Insulin Resistance
07/2008 - 04/2005
2Weight Loss (Weight Reduction)
07/2008 - 04/2005
1Mood Disorders (Mood Disorder)
07/2008
1Overactive Urinary Bladder (Overactive Bladder)
02/2007
1Overweight
04/2005
1Obesity
04/2005

Drug/Important Bio-Agent (IBA)

2RimonabantIBA
07/2008 - 04/2005
2HDL CholesterolIBA
07/2008 - 04/2005
2Triglycerides (Triacylglycerol)IBA
07/2008 - 04/2005
1CannabinoidsIBA
07/2008
1Glucose (Dextrose)FDA LinkGeneric
07/2008
1Insulin (Novolin)FDA Link
07/2008
1AS 8IBA
02/2007
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
04/2005

Therapy/Procedure

1Caloric Restriction
07/2008